Aichi-ken, Japan

Misato Hirano




Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Aichi, JP (2005)
  • Aichi-ken, JP (2006 - 2011)
  • Chita-gun, JP (2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Misato Hirano: Innovator in Pharmaceutical Chemistry

Introduction

Misato Hirano is a prominent inventor based in Aichi-ken, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the VR1 receptor. With a total of 6 patents to her name, her work has the potential to impact the treatment of various pain-related conditions.

Latest Patents

One of her latest patents involves substituted bicyclocarboxyamide compounds. This invention provides a compound that is useful for treating disease conditions caused by the overactivation of the VR1 receptor, such as pain in mammals. Another notable patent focuses on substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists. This invention outlines a compound that can be utilized in the development of new therapeutic agents targeting the same receptor.

Career Highlights

Throughout her career, Misato Hirano has worked with leading pharmaceutical companies, including Pfizer Corporation and Warner-Lambert Company. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Misato has collaborated with notable colleagues such as Kazunari Nakao and Takeshi Hanazawa. These partnerships have further enhanced her research capabilities and have led to innovative solutions in her field.

Conclusion

Misato Hirano's contributions to pharmaceutical chemistry and her innovative patents demonstrate her commitment to advancing medical science. Her work continues to pave the way for new treatments that can improve the quality of life for many individuals suffering from pain-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…